Sameh Tawfik

Array ( [id] => 8336165 [patent_doc_number] => 20120202875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'Method Of Treatment' [patent_app_type] => utility [patent_app_number] => 13/500408 [patent_app_country] => US [patent_app_date] => 2010-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7364 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313710 [patent_doc_number] => 20120190732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'Multifunctional Aptamer-Nucleic Acid Nanostructures for Tumor-Targeted Killing' [patent_app_type] => utility [patent_app_number] => 13/392735 [patent_app_country] => US [patent_app_date] => 2010-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16683 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9184075 [patent_doc_number] => 08624008 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-07 [patent_title] => 'Aptamer and detection method for C-reactive protein' [patent_app_type] => utility [patent_app_number] => 12/924225 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7562 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12924225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4612121 [patent_doc_number] => 07988959 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Method of treatment using organotypically cultured skin tissue comprising niks cells that express exogenous HIF-1a' [patent_app_type] => utility [patent_app_number] => 12/886976 [patent_app_country] => US [patent_app_date] => 2010-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21204 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/988/07988959.pdf [firstpage_image] =>[orig_patent_app_number] => 12886976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8294611 [patent_doc_number] => 08222396 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'SiRNA targeting proto-oncogene MET' [patent_app_type] => utility [patent_app_number] => 12/807526 [patent_app_country] => US [patent_app_date] => 2010-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34732 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12807526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943549 [patent_doc_number] => 20110104169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'REGULATOR GENES OF ANGIOGENESIS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 12/870165 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12423 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104169.pdf [firstpage_image] =>[orig_patent_app_number] => 12870165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4619377 [patent_doc_number] => 07999097 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'siRNA targeting beta secretase (BACE)' [patent_app_type] => utility [patent_app_number] => 12/806570 [patent_app_country] => US [patent_app_date] => 2010-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 35010 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/999/07999097.pdf [firstpage_image] =>[orig_patent_app_number] => 12806570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6600824 [patent_doc_number] => 20100322905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'Compositions and methods for treating pancreatic cancer' [patent_app_type] => utility [patent_app_number] => 12/856954 [patent_app_country] => US [patent_app_date] => 2010-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6396 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322905.pdf [firstpage_image] =>[orig_patent_app_number] => 12856954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6350939 [patent_doc_number] => 20100331214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'siRNA Targeting Survivin' [patent_app_type] => utility [patent_app_number] => 12/806513 [patent_app_country] => US [patent_app_date] => 2010-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 28803 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331214.pdf [firstpage_image] =>[orig_patent_app_number] => 12806513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615615 [patent_doc_number] => 20100323922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)' [patent_app_type] => utility [patent_app_number] => 12/806320 [patent_app_country] => US [patent_app_date] => 2010-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34764 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323922.pdf [firstpage_image] =>[orig_patent_app_number] => 12806320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580983 [patent_doc_number] => 20110294866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATING DEMENTIA COMPRISING SHRNA INHIBITING S100A9 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/851273 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5523 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294866.pdf [firstpage_image] =>[orig_patent_app_number] => 12851273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8956240 [patent_doc_number] => 08502015 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-08-06 [patent_title] => 'Method of inducing cancer' [patent_app_type] => utility [patent_app_number] => 12/831129 [patent_app_country] => US [patent_app_date] => 2010-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 4189 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12831129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8277295 [patent_doc_number] => 20120171170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'TREATMENT OF COLLAGEN GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A COLLAGEN GENE' [patent_app_type] => utility [patent_app_number] => 13/377888 [patent_app_country] => US [patent_app_date] => 2010-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 28694 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13377888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056253 [patent_doc_number] => 20120077867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Compositions And Methods For Treating Pancreatic Cancer' [patent_app_type] => utility [patent_app_number] => 13/376240 [patent_app_country] => US [patent_app_date] => 2010-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6199 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077867.pdf [firstpage_image] =>[orig_patent_app_number] => 13376240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543399 [patent_doc_number] => 08318691 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Treatment of tumors with genetically engineered herpes virus' [patent_app_type] => utility [patent_app_number] => 12/802443 [patent_app_country] => US [patent_app_date] => 2010-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3894 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12802443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5978279 [patent_doc_number] => 20110071208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'LIPID ENCAPSULATED DICER-SUBSTRATE INTERFERING RNA' [patent_app_type] => utility [patent_app_number] => 12/794701 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 36138 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071208.pdf [firstpage_image] =>[orig_patent_app_number] => 12794701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9574958 [patent_doc_number] => 08765370 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-01 [patent_title] => 'Inhibition-based high-throughput screen strategy for cell clones' [patent_app_type] => utility [patent_app_number] => 12/792924 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 13 [patent_no_of_words] => 7443 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12792924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9574958 [patent_doc_number] => 08765370 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-01 [patent_title] => 'Inhibition-based high-throughput screen strategy for cell clones' [patent_app_type] => utility [patent_app_number] => 12/792924 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 13 [patent_no_of_words] => 7443 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12792924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227810 [patent_doc_number] => 20120142013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'NUCLEIC ACID APTAMER CAPABLE OF BINDING SPECIFICALLY TO PANCREATIC CANCER CELLS OR TISSUES AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/375347 [patent_app_country] => US [patent_app_date] => 2010-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 8879 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13375347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571739 [patent_doc_number] => 08338384 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Method for treating ocular neovascularization' [patent_app_type] => utility [patent_app_number] => 12/785461 [patent_app_country] => US [patent_app_date] => 2010-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11764 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12785461 [rel_patent_id] =>[rel_patent_doc_number] =>)